BIOMAT Database Logo BIOMAT Database Logo

Vaginal PGE2 and intraamniotic PGF2 alpha for the termination of second trimester pregnancy. 1986

G Farmakides, and H Schulman, and A Fayemi, and A Fleischer, and J Mitchell, and P Blattner

UI MeSH Term Description Entries
D007267 Injections Introduction of substances into the body using a needle and syringe. Injectables,Injectable,Injection
D011247 Pregnancy The status during which female mammals carry their developing young (EMBRYOS or FETUSES) in utero before birth, beginning from FERTILIZATION to BIRTH. Gestation,Pregnancies
D011262 Pregnancy Trimester, Second The middle third of a human PREGNANCY, from the beginning of the 15th through the 28th completed week (99 to 196 days) of gestation. Midtrimester,Pregnancy, Second Trimester,Trimester, Second,Midtrimesters,Pregnancies, Second Trimester,Pregnancy Trimesters, Second,Second Pregnancy Trimester,Second Pregnancy Trimesters,Second Trimester,Second Trimester Pregnancies,Second Trimester Pregnancy,Second Trimesters,Trimesters, Second
D011458 Prostaglandins E (11 alpha,13E,15S)-11,15-Dihydroxy-9-oxoprost-13-en-1-oic acid (PGE(1)); (5Z,11 alpha,13E,15S)-11,15-dihydroxy-9-oxoprosta-5,13-dien-1-oic acid (PGE(2)); and (5Z,11 alpha,13E,15S,17Z)-11,15-dihydroxy-9-oxoprosta-5,13,17-trien-1-oic acid (PGE(3)). Three of the six naturally occurring prostaglandins. They are considered primary in that no one is derived from another in living organisms. Originally isolated from sheep seminal fluid and vesicles, they are found in many organs and tissues and play a major role in mediating various physiological activities. PGE
D011460 Prostaglandins F (9 alpha,11 alpha,13E,15S)-9,11,15-Trihydroxyprost-13-en-1-oic acid (PGF(1 alpha)); (5Z,9 alpha,11,alpha,13E,15S)-9,11,15-trihydroxyprosta-5,13-dien-1-oic acid (PGF(2 alpha)); (5Z,9 alpha,11 alpha,13E,15S,17Z)-9,11,15-trihydroxyprosta-5,13,17-trien-1-oic acid (PGF(3 alpha)). A family of prostaglandins that includes three of the six naturally occurring prostaglandins. All naturally occurring PGF have an alpha configuration at the 9-carbon position. They stimulate uterine and bronchial smooth muscle and are often used as oxytocics. PGF
D004359 Drug Therapy, Combination Therapy with two or more separate preparations given for a combined effect. Combination Chemotherapy,Polychemotherapy,Chemotherapy, Combination,Combination Drug Therapy,Drug Polytherapy,Therapy, Combination Drug,Chemotherapies, Combination,Combination Chemotherapies,Combination Drug Therapies,Drug Polytherapies,Drug Therapies, Combination,Polychemotherapies,Polytherapies, Drug,Polytherapy, Drug,Therapies, Combination Drug
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000028 Abortion, Induced Intentional removal of a fetus from the uterus by any of a number of techniques. (POPLINE, 1978) Embryotomy,Abortion (Induced),Abortion Failure,Abortion History,Abortion Rate,Abortion Technics,Abortion Techniques,Abortion, Drug-Induced,Abortion, Rivanol,Abortion, Saline-Solution,Abortion, Soap-Solution,Anti-Abortion Groups,Fertility Control, Postconception,Induced Abortion,Previous Abortion,Abortion Failures,Abortion Histories,Abortion Rates,Abortion Technic,Abortion Technique,Abortion, Drug Induced,Abortion, Previous,Abortion, Saline Solution,Abortion, Soap Solution,Abortions (Induced),Abortions, Drug-Induced,Abortions, Induced,Abortions, Previous,Abortions, Rivanol,Abortions, Saline-Solution,Abortions, Soap-Solution,Anti Abortion Groups,Anti-Abortion Group,Drug-Induced Abortion,Drug-Induced Abortions,Embryotomies,Failure, Abortion,Failures, Abortion,Group, Anti-Abortion,Groups, Anti-Abortion,Histories, Abortion,History, Abortion,Induced Abortions,Postconception Fertility Control,Previous Abortions,Rate, Abortion,Rates, Abortion,Rivanol Abortion,Rivanol Abortions,Saline-Solution Abortion,Saline-Solution Abortions,Soap-Solution Abortion,Soap-Solution Abortions,Technic, Abortion,Technics, Abortion,Technique, Abortion,Techniques, Abortion
D000282 Administration, Intravaginal The insertion of drugs into the vagina to treat local infections, neoplasms, or to induce labor. The dosage forms may include medicated pessaries, irrigation fluids, and suppositories. Administration, Vaginal,Drug Administration, Vaginal,Instillation, Vaginal,Intravaginal Administration,Vaginal Drug Administration,Vaginal Administration,Administration, Vaginal Drug,Administrations, Intravaginal,Administrations, Vaginal,Administrations, Vaginal Drug,Drug Administrations, Vaginal,Instillations, Vaginal,Intravaginal Administrations,Vaginal Administrations,Vaginal Drug Administrations,Vaginal Instillation,Vaginal Instillations

Related Publications

G Farmakides, and H Schulman, and A Fayemi, and A Fleischer, and J Mitchell, and P Blattner
Comparison between intraamniotic PGF2 alpha and vaginal PGE2 for second-trimester abortion.
July 1980, Obstetrics and gynecology,
G Farmakides, and H Schulman, and A Fayemi, and A Fleischer, and J Mitchell, and P Blattner
Intraamniotic ethacridine lactate instillation versus vaginal PGE1 in second trimester termination of pregnancy.
June 2006, European journal of obstetrics, gynecology, and reproductive biology,
G Farmakides, and H Schulman, and A Fayemi, and A Fleischer, and J Mitchell, and P Blattner
Termination of second trimester pregnancy with gemeprost vaginal pessaries and intra-amniotic PGF2 alpha. A comparative study.
April 1989, European journal of obstetrics, gynecology, and reproductive biology,
G Farmakides, and H Schulman, and A Fayemi, and A Fleischer, and J Mitchell, and P Blattner
Termination of second trimester pregnancy with a long-acting vaginal pessary containing 15-methyl-PGF2 alpha methyl ester.
April 1983, International journal of gynaecology and obstetrics: the official organ of the International Federation of Gynaecology and Obstetrics,
G Farmakides, and H Schulman, and A Fayemi, and A Fleischer, and J Mitchell, and P Blattner
Vaginal misoprostol in termination of second trimester pregnancy.
April 2000, The journal of obstetrics and gynaecology research,
G Farmakides, and H Schulman, and A Fayemi, and A Fleischer, and J Mitchell, and P Blattner
Second-trimester abortion after vaginal termination of pregnancy.
August 1972, Lancet (London, England),
G Farmakides, and H Schulman, and A Fayemi, and A Fleischer, and J Mitchell, and P Blattner
Second-trimester abortion after vaginal termination of pregnancy.
June 1972, Lancet (London, England),
G Farmakides, and H Schulman, and A Fayemi, and A Fleischer, and J Mitchell, and P Blattner
Experience with PGF2 alpha in mid-trimester pregnancy termination in Ibadan.
January 1979, African journal of medicine and medical sciences,
G Farmakides, and H Schulman, and A Fayemi, and A Fleischer, and J Mitchell, and P Blattner
Therapeutic termination of second trimester pregnancy with vaginal misoprostol.
April 2001, Journal of the Medical Association of Thailand = Chotmaihet thangphaet,
G Farmakides, and H Schulman, and A Fayemi, and A Fleischer, and J Mitchell, and P Blattner
Intrauterine PGF2 alpha infusion for termination of pregnancies with second-trimester rupture of membranes.
January 1992, Obstetrics and gynecology,
Copied contents to your clipboard!